1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137–2150
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
3. Institut RK. Zentrum für Krebsregisterdaten. Zentrum frür Krebsregisterdaten. Berlin: Robert Koch Institut; 2015. Zentrum für Krebsregisterdaten
4. Hartmann S, Kriegebaum U, Kuchler N, Lessner G, Brands RC, Linz C, et al. (2013) Efficacy of cetuximab and panitumumab in oral squamous cell carcinoma cell lines: prognostic value of MAGE-a subgroups for treatment success. J Craniomaxillofac Surg Off Publ European Assoc Craniomaxillofac Surg 41:623–629
5. Song Q, Li X, Li B (2015) [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis]. Lin chuang er bi yan hou tou jing wai ke za zhi. J Clin Otorhinolaryngol Head Neck Surg 29:67–75